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Effect of using the same vs different order for second readings of screening mammograms on rates 29 
of breast cancer detection: A randomized clinical trial  30 
Importance: Interpreting breast screening mammograms is a difficult repetitive task that can result 31 
in missed cancers and false positive recalls. In the UK, two film readers independently evaluate each 32 
mammogram to search for signs of cancer, and examine digital mammograms in batches. However, 33 
a vigilance decrement (reduced detection rate with time on task) has been observed in similar 34 
settings.  35 
Objective: To determine the effect of changing the order for the second film reader of batches of 36 
screening mammograms on rates of breast cancer detection.  37 
Design, Setting, and Participants: A multi-centre, double-blind, cluster randomised controlled trial 38 
conducted at 46 specialised breast screening centres from the National Health Service Breast 39 
Screening Programme in England for 1 year, (all between 20th December 2012 and 3rd November 40 
2014). 360 readers participated (mean 7.8 readers per centre), 186 radiologists, 143 radiography 41 
advanced practitioners and 31 breast clinicians, all fully qualified to report mammograms in the NHS 42 
breast screening programme. 43 
Intervention: The two readers examined each batch of digital mammograms in the same order in 44 
the control group and in the opposite order to one another in the intervention group. 45 
Main Outcomes and Measures: The primary outcome was cancer detection rate; secondary 46 
outcomes were rates of recall and disagreements between readers. 47 
Results: Among 1,194,147 women (mean age 59.3, sd 7.49) who had screening mammograms 48 
(596642 in the intervention group; 597505 in the control group), the images were interpreted in 49 
37,688 batches [median batch size 35 (IQR 16-46)], with each reader interpreting median 176 50 
batches (IQR 96 to 278). After completion of all subsequent diagnostic tests, a total of 10,484 cases 51 
of breast cancer were detected (0.88%). There was no significant difference in cancer detection rate 52 
[5272 (0.88%) vs 5212 (0.87%), difference 0.011% points 95%CI -0.022 to 0.045], recall rate, [24681 53 
(4.14%) vs 24894 (4.17%),  difference -0.030% points 95%CI -0.101 to 0.042) or rate of reader 54 
disagreements [20,471 (3.43%) vs 20793 (3.48%), difference -0.048% points 95%CI -0.113 to 0.018,] 55 
between intervention and control groups.  56 
Conclusions and Relevance: Interpretation of batches of mammograms by qualified screening 57 
mammography readers using a different order versus the same order for the second reading 58 
resulted in no significant difference in rates of detection of breast cancer. 59 
Trial Registration: www.isrctn.com identifier: ISRCTN46603370 60 
61 
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Introduction 62 
Breast cancer screening currently detects 8.6 cancers per thousand women screened triennially 63 
(equivalent to 18,000 cancers per year) in the UK1 and 4.2 cancers per thousand women screened 64 
annually in the US. 2 However, another 2.9 cancers per thousand women screened in the UK 3 65 
(equivalent to 6,030 cancers per year) 1  and 0.9 cancers per thousand women screened in the US 66 
are detected between screening rounds in screened women. 2  These arise through cancers growing 67 
between screening rounds, and cancers missed at screening. An additional 3.4% of women in the UK 68 
(70,715 each year) 1 and 9.3% of women in the US 2 experience false positive recalls at each 69 
screening round. 70 
Interpreting screening mammograms is a difficult and repetitive visual search task, where 71 
characteristics of cancer are disguised amongst background breast parenchyma resulting in false 72 
positive recalls and missed cancers. In similar visual search tasks a vigilance decrement of decreasing 73 
detection rates with time on task has been observed in a large number of psychological laboratory 74 
experiments 4 5 for example assembly line inspection tasks, 6 airport baggage screening, 7 driving 8 75 
piloting aeroplanes9 and operating military drones. 10 An effect similar to the vigilance decrement 76 
has been observed when examining tests sets of x-rays including mammograms in laboratory 77 
conditions although the phenomenon has not previously been explored in breast screening 78 
practice.11,12 79 
In the UK two film readers independently examine each woman’s mammograms for signs of cancer. 80 
In this study we investigated whether there is a vigilance decrement to detect cancer in breast 81 
screening practice, and whether changing the order in which the two experts examined the batch of 82 
mammograms could increase the cancer detection rate, through readers experiencing peak vigilance 83 
at differing points within the reading batch when examining different women’s mammograms. 84 
 85 
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Methods 86 
Study Design 87 
The Changing Case Order to Optimise Patterns of Performance in Screening (CO-OPS) pragmatic 88 
double blind cluster randomised controlled trial was designed to determine whether there is a 89 
vigilance decrement in breast cancer screening, and whether changing the order in which the cases 90 
are presented can increase cancer detection rate.  91 
Ethical approval was granted by the Coventry and Warwickshire National Health Service (NHS) 92 
Research Ethics Committee on 27 June 2012 (Reference 12/WM/0182) and written informed 93 
consent sought from the director of breast screening at each centre. The trial protocol is provided in 94 
supplement 1 and published elsewhere 13 and statistical analysis plan (supplement 2) was finalised 95 
before any data were collected.  96 
Intervention and Outcomes 97 
The study compared two parallel groups, each split into two sub-groups to ensure blinding of the 98 
readers. The intervention group involved the two readers reading the batch in the opposite order to 99 
each other; one forwards, one in reverse. Hence, the two sub-groups: first reader forwards, second 100 
reader reverse, and first reader reverse, second reader forward. The control group required the 101 
readers to read the batch in the same order as each other; the sub-groups being either both 102 
forwards (which is current practice) or both in reverse (to maintain the blinding of a reader to trial 103 
group, as they would be aware that they are reading a batch in reverse). Thus each batch (cluster) 104 
was randomised with equal probability to one of four groups.  105 
The primary outcome was cancer detection rate, (number of women with cancer detected as a 106 
proportion of all women screened) as this is the clinically relevant outcome of interest. Secondary 107 
outcomes of recall rate (secondary outcome 1) and rate of disagreement between the readers 108 
(secondary outcome 2) are designed to examine the proposed mechanism of action. The idea is that 109 
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reversing the order for one reader results in high vigilance states occurring for the two readers when 110 
examining different women’s mammograms, so the cancers are detected by at least one of the 111 
experts, as outlined in figure 1. If a reader in a high vigilance state detected a cancer missed by their 112 
colleague in a low vigilance state, then this would lead to a disagreement between them. All 113 
disagreements are ‘arbitrated’ either by a third reader or group of readers for the final decision of 114 
whether to recall the woman for further tests. Assuming the arbitration process performs better 115 
than random chance the increases in disagreements would lead to increases in recall rate and cancer 116 
detection rate.  117 
 118 
Participants 119 
Centres were recruited at radiology meetings, through local radiology, radiography and quality 120 
assurance groups, and through direct telephone and email contact. The study comprised 46 breast 121 
screening centres using digital mammography, each consisting of groups of between 1 and 3 122 
hospitals sharing the same computer system for storing women’s health records. Characteristics of 123 
breast screening centres in England which took part in the trial in comparison to those which did not 124 
is provided in table e1. The trial ran for 1 year at each centre, with individual centres starting the 125 
study when local consent and research and development approvals were obtained, (start dates were 126 
all between 20th December 2012 and 4th November 2013). One centre completed only 4 months of 127 
the study due to local technical and workforce issues. 128 
Mammograms from women attending routine breast cancer screening at these centres during the 129 
study period were included. These were arranged into batches of around 40 women as is standard 130 
practice in the UK, and all mammograms taken during the study period were included in the trial, 131 
regardless of when they were examined. Each batch contained all cases from a single mammography 132 
acquisition machine in a single day. Informed consent was at the centre level, with consent of 133 
individual women considered impractical for this system level intervention. In the UK women age 50 134 
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to 70 are invited to breast screening every 3 years, this study also includes women aged 47-49 and 135 
71-73 participating in the age extension trial (NCT01081288), and a small proportion of older women 136 
(2.3% of women in the trial) who self-refer as part of the programme.  Women who presented to 137 
clinics symptomatically and for high familial risk were excluded.  138 
All readers undergo formal training and are accredited by the NHS Breast Screening Programme. 139 
They are required to read a minimum of 5,000 cases per year, participate in assessment clinics, 140 
formally audit their own performance against their peers,  and maintain ongoing professional 141 
development including participating annually in the Personal Performance in Mammographic 142 
Screening (PERFORMS) test set.14 Each centre annually measures and reports results against targets 143 
including recall rate, cancer detection rate, and small cancer detection rate, and continuously audits 144 
performance through monthly review of interval cancers diagnosed symptomatically between 145 
screening rounds, 14  and monthly checks of mammography acquisition and display equipment and 146 
reading room background light levels.15 Each woman’s mammograms are examined by two readers 147 
co-located in the same breast screening centre. Readers are instructed to examine the batches 148 
independently, but can access the other reader’s decision by opening the patient records. In 16 of 149 
the 46 centres workflow systems were designed to blind reader 2 to the decision of reader 1. All 150 
centres used arbitration when the two readers disagreed, with 13 centres using a single 3rd reader, 151 
and 33 centres using group consensus of 2 or more readers. 152 
Randomisation and Blinding  153 
The randomisation took place immediately prior to opening each batch for examination using the 154 
Intersystems Caché $RANDOM function within the computer software that the UK National Breast 155 
Screening Service (NBSS) uses to manage the work. After randomisation the software automatically 156 
displayed the cases in the chosen order to the first and second reader. Readers were aware of the 157 
reading order but were blinded to trial group. The trial statistician and the women screened were 158 
also blinded to trial group. The unit of randomisation was a batch of mammograms, whereas the 159 
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unit of observation was the individual mammogram. Simple randomisation was used without 160 
stratification or minimisation due to the large number of clusters randomised.  161 
Data collection 162 
The data were collected via an adaptation to the NBSS computer system, which created new tables 163 
within the software to record data items pertaining to the trial. The outcomes for every woman 164 
screened (including both readers’ decision, time of decision, and results of all follow-up tests 165 
including biopsy) were added to NBSS as part of each centre’s annual reporting requirements, to 166 
reduce missing data. The data was extracted through NBSS from each centre, exporting data in Excel 167 
format. The datasets from each centre were merged using Excel and R [v 3.0.3 in RStudio v 168 
0.98.501]. Cancer was defined as needle biopsy or surgery positive for ductal carcinoma in situ or 169 
invasive cancer. Recall for further tests was taken directly from NBSS, which records this decision to 170 
enable the follow-up appointment to be made. Disagreement was defined by examining whether 171 
the recommendation of whether to recall differed between the first and second readers.  172 
Sample Size 173 
Prior to the study (year 2011-12) the breast cancer detection rate in the UK was 7.8 per thousand 174 
women screened. 16 Three years of observational data on patterns of cancer detection with time on 175 
task was extracted from routine records at eight breast screening centres in one English region.  This 176 
suggested that the intervention may result in one extra cancer detected per 2000 women screened, 177 
an increase to 8.3 per thousand women screened.  To detect such an increase required a sample size 178 
of 501,361 women in each group, using a 5% significance level and 80% power. The trial had a 179 
cluster design, the unit of randomisation being the batch, so the sample size needed to be inflated 180 
by the design effect. The inter-cluster correlation coefficient was estimated to be 0.002, resulting in 181 
a design effect of 1.09, assuming an average cluster size of 40. Hence, the total sample size required 182 
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was 1,093,780, which is equivalent to the annual caseload of 44 centres. There were no interim 183 
analyses or stopping rules. 184 
Statistical analysis 185 
We used multivariable multilevel logistic regression to analyse factors associated with breast cancer 186 
detection, recall and disagreement rates due to the hierarchical nature of the datasets. Analysis was 187 
intention to treat, with those not receiving the intervention as allocated included in the analysis. 188 
However, women lost to follow-up, technical recalls (mammograms were of insufficient quality to 189 
read), and second screening of the same woman were excluded. A three level multilevel model for 190 
woman screened (level 1) nested in a batch (level 2) and within a center (level 3) was specified. Four 191 
models were constructed for each of the rates stated above. The first model, a null model without 192 
any variable was specified to decompose the amount of variance that existed at each level, the 193 
second model included the intervention only, the third model included adjustment for known 194 
factors associated with cancer and recall (woman’s age and whether she had previously attended 195 
screening) while the fourth model added the intervention to the adjusted model. All multilevel 196 
modelling was performed using MlwiN 2.35 17 called from Stata statistical software for Windows 197 
version 14 18 using runmlwin routine. For the multilevel logistic regression models, (iterative 198 
generalized least squares; penalised quasi-likelihood) IGLS PQL2 estimation was used. 19 Two-tailed 199 
tests were used, with p values <0.05 considered significant. The fixed effects (i.e. measures of 200 
association) are presented as adjusted odds ratios with their corresponding 95% confidence intervals 201 
(CIs). Measures of random effects included intra-cluster correlation (ICC) and median odds ratio 202 
(MOR). 20, Merlo, #9 The ICC was calculated by the linear threshold according to the formula used by 203 
Snijders et. al. 21 while MOR is a measure of unexplained cluster heterogeneity. Methods used for 204 
calculating MOR have been described elsewhere 20, Merlo, #9,22. Positive Predictive Value was also 205 
calculated in the intervention and control groups as the proportion of recalled cases in which cancer 206 
was detected. 207 
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The same models were constructed for three pre-defined sub-groups: women aged under 53 (in 208 
whom the intervention may be more effective due to higher breast density increasing the task 209 
difficulty); the first and last 5 cases in each batch (where any difference in vigilance would be at its 210 
maximum in the intervention group); and the first batch of the day (to examine whether the 211 
effectiveness of the intervention may be masked by examining a number of batches in succession). 212 
An exploratory post-hoc sub group analysis of cases which are not in the first batch of the day for 213 
either reader used the same model structure (to investigate intervention effectiveness when readers 214 
may be fatigued). 215 
An exploratory post-hoc analysis to measure whether there is a vigilance decrement of decreasing 216 
sensitivity to detect cancer with time spent on task, the position in the batch (i.e. 1st, 2nd, 3rd …) was 217 
added as a variable to the unadjusted and adjusted models of cancer detection outlined above. For 218 
this analysis the cancer detection rate outcome was personalised to the individual reader who first 219 
examined the case, so the outcome had an additional requirement of being correctly identified by 220 
the first reader for recall, as well as having cancer identified on follow-up tests. The same modelling 221 
approach was applied to recall rate, to measure any systematic change with time on task. In this 222 
case it was the recall rate for the first reader, rather than overall from the process that was analysed. 223 
Further exploratory post-hoc analysis was conducted to determine whether the lack of effect of the 224 
intervention was associated with reader 2 not being blinded to the decision of reader 1 at some trial 225 
centres. Including only the sub-group of centres in which reader 2 was blinded to the decision of 226 
reader 1, cancer detection rates and recall rates in the intervention group were calculated, and 227 
compared to those in the control group.  228 
Results 229 
Flow of Women in the CO-OPS Trial  230 
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1,207,633 women were included in the trial, see figure 2. There were three causes of loss to follow 231 
up: 258 (0.02%) were recalled for further tests from screening but did not attend, 233 (0.02%) had 232 
an inconclusive needle biopsy result but refused further tests, and 298 women (0.02%) had missing 233 
data in the NBSS system. An additional 12,426 cases (1.03%) were judged of insufficient quality for 234 
analysis (Technical recall) by the first reader so were not read within batch and could not be included 235 
in the analysis, and 271 (0.02%) cases were excluded because the same woman had already been 236 
screened that year and included in the trial. This occurred primarily when women moved house and 237 
GP practice and consequently were re-invited more quickly than intended.  238 
The intervention and control groups were well matched for baseline characteristics including the age 239 
and previous attendance of the women screened and batch length, as detailed in table 1. 240 
Mammograms were examined by 360 qualified readers, of which 186 were radiologists, 143 were 241 
radiography advanced practitioners and 31 were breast clinicians. The median batch length was 35 242 
cases (quartiles 16 and 46). Each reader examined a median of 5640 cases, (IQR 2599 to 8458), in a 243 
median of 176 batches (IQR 96 to 278) including cases in both the intervention and control groups. 244 
Between 1 and 26 batches were examined by each reader in a single day (median 2 IQR 1 to 4). Each 245 
centre examined between 8152 and 72714 cases (median 25540 cases). 246 
 247 
Outcomes 248 
 249 
The primary outcome, cancer detection rate, was 0.88% (5272/596642) in the intervention group 250 
and 0.87% (5212/597505) in the control group (difference 0.011% points 95%CI -0.022 to 0.045), see 251 
table 2. The intervention did not affect cancer detection rate in the unadjusted (OR=1.01 95%CI 0.96 252 
to 1.06) or adjusted models (OR=1.01 95%CI 0.97 to 1.06), see table 3 and e2. In the adjusted model, 253 
cancer detection rate increased with each increasing year of age (OR=1.052 95%CI 1.048 to 1.055) 254 
and was higher in women who had not previously attended screening (OR=1.73 95%CI 1.62 to 1.86). 255 
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The intervention also had no effect in any of the sub-groups of younger age, first and last 5 cases in 256 
the batch, the first batch of the day for both readers, or in batches examined second in the day or 257 
later by both readers in either the adjusted or unadjusted models. For batches read first in each 258 
workday by both readers cancer detection rate was 0.83% (580/70071, 95%CI 0.76% to 0.89%) in the 259 
intervention group and 0.88% (623/70715, 95%CI 0.81% to 0.95%) in the control group (difference -260 
0.053% points 95%CI -0.149 to 0.043). For batches read second or subsequent in each workday by 261 
both readers cancer detection rate was 0.85% (2472/289786, 95%CI 0.82% to 0.89%) in the 262 
intervention group and 0.85% (2473/290671, 95%CI 0.82% to 0.88%) in the control group (difference 263 
0.002% points 95%CI -0.045 to 0.050). 264 
  265 
12 
 
 266 
The intervention did not affect either of the secondary outcomes, recall rate or rate of 267 
disagreements. The recall rate was 4.14% (24681/596642) in the intervention group and 4.17% 268 
(24894/597505) in the control group (difference -0.030% points 95%CI -0.101 to 0.042), see table 2. 269 
The rate of disagreement was 3.43% in the intervention group (20471/596294) and 3.48% 270 
(20793/597387) in the control group (difference -0.048% points 95%CI -0.113 to 0.018), as detailed 271 
in table 2. The intervention had no effect on recall rate in the unadjusted (OR=0.993 CI 0.974 to 272 
1.013) or adjusted (OR=0.997 CI 0.978 to 1.016) models, (see supplementary table e3) or on rate of 273 
disagreement in the unadjusted (OR=0.994 CI 0.971 to 1.019) or adjusted model (OR=0.997 CI 0.974 274 
to 1.020), see supplementary table e4. Recall rate was higher with each year of age of the woman 275 
screened (OR 1.008 CI 1.007 to 1.010), and was higher in women who had not previously attended 276 
breast screening (OR=2.89 CI 2.82 to 2.97). Rate of disagreement was also higher for women at their 277 
first screening appointment (OR=2.17 CI 2.11 to 2.24) but lower with each year of increasing age of 278 
the woman screened (OR=0.994 CI 0.992 to 0.996). The positive predictive value (PPV) was 21.4% 279 
(95% CI 20.8% to 21.9%) in the intervention group and 20.9% (95% CI 20.4% to 21.4%) in the control 280 
group (difference 0.420% points 95%CI -0.299 to 1.139). The intervention had no effect on any of the 281 
sub-groups (Younger women, first and last cases in the batch, first batch of the day, and second or 282 
subsequent batch of the day) for either the adjusted or unadjusted models for either recall rate or 283 
rate of disagreements. For batches read first in each workday by both readers recall rate was 4.02% 284 
(2818/70071, 95%CI 3.88% to 4.17%) in the intervention group and 4.11% (2904/70715, 95%CI 285 
3.96% to 4.25%) in the control group (difference -0.085% points 95%CI -0.291 to 0.121), and rate of 286 
disagreements was 3.61% (2531/70071, 95%CI 3.47% to 3.75%) in the intervention group and 3.75% 287 
(2653/70715, 95%CI 3.61% to 3.89%) in the control group (difference -0.140% points 95%CI -0.336 to 288 
0.057). For batches read second or subsequent in each workday by both readers recall rate was 289 
4.10% (11868/289786, 95%CI 4.02% to 4.17%) in the intervention group and 4.15% (12068/290671, 290 
95%CI 4.08% to 4.22%) in the control group (difference -0.056% points 95%CI -0.159 to 0.046), and 291 
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rate of disagreements was 3.23% (9359/289785, 95%CI 3.17% to 3.29%) in the intervention group 292 
and 3.28% (9533/290670, 95%CI 3.22% to 3.35%) in the control group (difference -0.050% points 293 
95%CI -0.141 to 0.041). 294 
Exploratory post-hoc analysis showed that cancer detection rate for individual readers did not 295 
change with time spent on task, as represented by near identical odds of detecting cancer between 296 
the first and fortieth case (OR=0.987, 95%CI 0.929 to 1.048). Results were very similar in the model 297 
adjusted for the characteristics of the woman screened (OR=0.995 95%CI 0.938 to 1.055), 298 
supplementary table e5. 299 
Exploratory post-hoc analysis showed that recall rate for individual readers (the proportion of 300 
women that one reader determined should be recalled) reduced with time on task. The odds of 301 
recall decreased over the course of examining 40 cases (OR= 0.83, 95% CI 0.81 to 0.85). The 302 
reduction was similar in the model adjusted for woman’s age and previous attendance (OR=0.89 303 
95%CI 0.87 to 0.91), see supplementary table e6. The mean change over the course of 40 cases was 304 
a reduction in recall rate from 6.4% (position 1) to 4.6% (position 40), with the trend continuing in 305 
longer batches, see figure 3.  306 
Further exploratory post-hoc analysis indicated that there was also no effect of the intervention 307 
when readers were blinded to one another’s decision. 366,824 cases were read in the trial at the 16 308 
centres which blind reader 2 to reader 1 decision. In those centres the cancer detection rate was 309 
0.88% (1603/181482, 95%CI 0.84% to 0.93%) in the intervention group and 0.87% (1611/185342, 310 
95%CI 0.83% to 0.91%) in the control group (difference 0.014% points, 95% CI -0.046 to 0.074). 311 
Similarly recall rate was 4.23% (7669/181482 95%CI 4.13% to 4.32%) in the intervention group and 312 
4.23% (7847/185342, 95%CI 4.14% to 4.33%) in the control group (difference -0.008% points, 95%CI 313 
-0.138 to 0.122). 314 
 315 
 316 
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Discussion 317 
We examined whether an intervention to change the order in which readers examine breast 318 
screening cases could improve cancer detection rate. We randomised 1.2 million women in batches 319 
of approximately 35 to intervention or control groups. The intervention did not influence cancer 320 
detection rate, recall rate, or rate of disagreement between readers. There was no pattern of 321 
decreasing cancer detection rate with time on task as predicted by previous research on vigilance 322 
decrements as a psychological phenomenon. Instead there was a gradual decrease in recall rate, 323 
with an increase in positive predictive value and a decrease in false positive recall of women with 324 
time on task. This may reinforce and explain previous observational research which identifies that 325 
recall rate is reduced when grouping women’s cases into batches. 23  326 
This randomised controlled trial in 1.2 million women was adequately powered to answer the 327 
research questions, with over half of the English breast screening service taking part. Effects were 328 
measured in a wide range of hospitals, increasing generalisability. Integration into the existing 329 
computer systems and reporting mechanisms resulted in very little loss to follow-up (less than 0.1%). 330 
Design of the trial computer system was iterative with high user involvement, which increased 331 
practicality and facilitated recruitment.  332 
This study has several limitations. First, the main limitation is that reading conditions were not 333 
controlled so whilst effectiveness in screening practice was measured, efficacy in ideal conditions 334 
was not evaluated. In this large pragmatic trial we aimed to measure the effects of the intervention 335 
applied to current clinical practice in the UK, and we did not control for or measure working 336 
conditions, some of which may affect whether there is a vigilance decrement.  Second, all readers 337 
would have met the minimum NHSBSP standards for reading volume, although we did not specify or 338 
measure the length of each readers work week, the proportion of their time spent working in breast 339 
screening or reading mammograms, the number of work hours or type of work activities each day, 340 
number of breaks taken or self-perceptions of fatigue. Similarly whilst there are programme wide 341 
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auditing methods for reader performance,14 there will also be centre level variation in management 342 
of individual performance which we did not record. Third, the trial did not attempt to implement 343 
blinding of reader 2 to the decision of reader 1 where this was not standard practice, as limiting 344 
reader’s access to computerised and paper notes was not considered possible without 345 
compromising patient safety. Fourth, 13% of women in the intervention group did not receive the 346 
intervention as intended. The trial software automatically detected these events, which occurred 347 
when readers manually overrode the case order and revisited the same case or used barcodes to 348 
identify individual cases. These women were included in the intention to treat analysis.  349 
 350 
The trial results were unexpected, and contradict previous research on the vigilance decrement in 351 
other fields.5 The vigilance decrement phenomenon has been reported in many peer reviewed 352 
publications,5 but was not observed in this large randomised controlled trial. These previous studies 353 
were primarily undertaken in psychology laboratories rather than in real life settings. Gur et al. 24 354 
demonstrated that performance in experimental conditions and in clinical practice may be very 355 
different, suggesting that there is a very different set of incentives in these two settings for the 356 
reader.  Hancock contends that the vigilance decrement is entirely a phenomenon created by the 357 
conditions designed to measure it. 25 Another explanation for not observing any vigilance decrement 358 
is simply that the sessions were too short, however, batches of 40 cases take 20-30 minutes to 359 
examine,26 and the vigilance decrement is usually complete 25 to 35 minutes into the task.5 The 360 
experienced specialists in this study could be less prone to a vigilance decrement, as was found in 361 
experienced CCTV operators reviewing a test film. 27 The vigilance decrement phenomenon may be 362 
associated with an increase in recall threshold rather than a reduction in performance 28 and if 363 
readers already have a low recall threshold so are recalling cases with minimal indications of cancer 364 
on the mammograms this may translate to an increase in specificity with minimal decrease in 365 
sensitivity. In addition, we have not yet tested the secondary outcome of interval cancer rate (rate of 366 
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cancers detected symptomatically between screening rounds). If there was a pattern in number of 367 
interval cancers with time on task then this may provide evidence of a vigilance decrement. This will 368 
be investigated through future analysis of 3 year follow-up data. However we are unlikely to observe 369 
such a pattern, because interval cancer rate is inversely proportional to cancer detection rate and 370 
this does not change with time on task, and because all cases recalled by one reader did receive a 371 
reference standard of peers (independent examination by another reader followed by examination 372 
by a third reader or group of readers) and 60% received follow up tests which included ultrasound 373 
and biopsy as appropriate. Furthermore the increase in recall rate at the beginning of the batch is 374 
many times larger than the total number of interval cancers at screening. 1  375 
A reduction in recall rate with time spent on task has not previously been observed in breast cancer 376 
screening. However, an observational study has indicated that examining batches of women’s 377 
mammograms in one sitting, rather than one-by-one reduces the overall recall rate with no change 378 
in cancer detection rate. 23   379 
The systematic reduction in recall rate with time on task for an individual reader did not translate 380 
into differences between the intervention and control group (double reading) in overall recall rate or 381 
rate of disagreements between readers. There are several possible explanations. The mechanism of 382 
action is dependent upon the increased recall rates acting upon the same cases in the control group 383 
and different cases in the intervention group. However, the situation is complex. Different readers 384 
have different recall thresholds, and different abilities to detect each type of mammographic 385 
abnormality (eg spiculated masses, asymmetries, architectural distortions etc). Furthermore each 386 
mammogram has overlapping tissue and many features which may appear suspicious. Therefore for 387 
any particular pair, the increase in cases recalled at the beginning of the session may not manifest in 388 
recalling the same cases. If this is the case, then the intervention would not affect overall recall rate, 389 
but it would affect who is recalled, with more women recalled at the beginning of the batch in the 390 
control group, and recalls spread more evenly throughout the batch in the intervention group.  391 
17 
 
 392 
The implications for practice are two-fold. Firstly the intervention of two readers examining a batch 393 
of mammograms in the opposite rather than the same order is not effective in increasing cancer 394 
detection rate. We have found no evidence of harms from the intervention; however some 395 
participating readers reported that it was more difficult to examine cases in reverse order as they 396 
also had to reverse associated paperwork. This result is only generalizable to population screening 397 
programmes which use two readers to examine mammograms separately. These include the UK NHS 398 
breast screening programmes where double reading of mammograms was recommended and 399 
became mandatory following the transition to fully digital mammography,14 European population 400 
screening programmes where double reading is recommended and implemented, 29 and Australia 401 
where double reading is considered preferable30 because it increases sensitivity,31 but not 402 
mandated. In the US the Mammography Quality Standards Act and the FDA do not require double 403 
reading of mammograms, the decision is made by professional societies and individual centres, and 404 
in practice it rarely happens.   405 
Secondly, for individual readers recall rate decreases with time spent on task for up to 60 cases, with 406 
no concurrent change in cancer detection rate. Therefore we suggest that examining cases in 407 
batches of up to 60 is likely to be beneficial. This result was found across 360 readers, encompassing 408 
more than half of the NHS Breast Screening Programme in England. Therefore it is likely to be 409 
generalisable to screening in England, and may be generalisable across all breast screening 410 
programmes using batch reading. Examining mammograms in batches is now standard practice in 411 
high volume population breast screening programmes worldwide, with evidence that batch reading 412 
increases specificity.23 However batch reading is not always used, particularly when case volumes 413 
are low, such as in practices serving smaller populations. Batch reading is routine for other imaging 414 
studies not involving direct radiologist/patient contact with radiology information systems designed 415 
for this practice. 416 
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 417 
Conclusion 418 
Interpretation of batches of mammograms by qualified screening mammography readers using a 419 
different order versus the same order for the second reading resulted in no significant difference in 420 
rates of detection of breast cancer. 421 
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Table 1 Baseline characteristics for intervention and control groups 541 
 542 
 Intervention Control 
Individual level   
Mean age of women screened 
(sd) 
59.3 (7.48) 59.3 (7.49) 
Number who have previously 
attended screening (%) 
126,490 / 596,642 (21.2%) 128,217 / 597,505 (21.5%) 
 
Cluster level 
  
Median batch length 
(quartiles) 
35 (16,46) 35 (16,45) 
Median number of screenings 
examined by each reader 
(quartiles) 
2,848 (1,469 , 4,385) 2,891 (1,543 , 4,458) 
Median number of batches 
examined by each reader 
(quartiles) 
86 (52,143) 91 (51,138) 
Median number of screenings 
examined at each centre 
(quartiles) 
12,496 (8,997 , 16,523) 12,908 (9,529 , 16,418) 
Median number of batches 
examined at each centre  
(quartiles) 
376 (282,502) 364 (272,521) 
 543 
  544 
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Table 2. Primary and secondary outcomes in intervention and control groups. 545 
Cancer detection rate, recall rate and rate of disagreement between readers in screenings of 546 
previous attenders, screenings of previous non-attenders and all screenings. 547 
 548 
Outcome Intervention  Control Difference 
 
Primary outcome: Cancer detection rate 
 All screenings (CI) 0.88% (0.86% - 0.91%) 
5,272/596,642  
0.87% (0.85% - 0.90%) 
5,212/597,505  
0.011% points  
(-0.022 - +0.045) 
 
 Screenings of previous 
attenders (CI) 
 
0.90% (0.87% - 0.92%) 
4,214/470,152  
0.88% (0.85% - 0.91%) 
4,122/469,288  
0.018% points  
(-0.020 - +0.056) 
   
 Screenings of previous 
non-attenders (CI) 
 
0.84% (0.79% - 0.89%) 
1,058/126,490 
0.85% (0.80% - 0.90%) 
1,090/128,217  
-0.014% points  
(-0.085 - +0.057) 
Secondary outcome: Recall Rate 
 All screenings (CI) 4.14% (4.09% - 4.19%) 
24,681/596,642  
4.17% (4.12% - 4.22%)  
24,894/597,505  
-0.030% points  
(-0.101 - +0.042) 
     
 Screenings of previous 
attenders (CI) 
 
3.15% (3.10% - 3.20%) 
14,819/470,152  
3.17% (3.12% - 3.22%)  
14,869/469,288  
-0.016% points  
(-0.087 - +0.054) 
 Screenings of previous 
non-attenders (CI) 
 
7.80% (7.65% - 7.94%) 
9,862/126,490  
7.82% (7.67% - 7.97%)  
10,025/128,217  
-0.022% points  
(-0.231 - +0.186) 
Secondary outcome: Disagreement rate between readers 
 All screenings (CI) 3.43% (3.39% - 3.48%) 
20,471/596,294  
3.48% (3.43% - 3.53%) 
20,793/597,387 
-0.048% points  
(-0.113 - +0.018) 
     
 Screenings of previous 
attenders (CI) 
 
2.73% (2.69% - 2.78%) 
12,850/469,869  
2.76% (2.71% - 2.80%)  
12,937/469,215  
-0.022% points  
(-0.088 - +0.044) 
 Screenings of previous 
non-attenders (CI) 
 
6.03% (5.90% - 6.16%) 
7,621/126,425  
6.13% (6.00% - 6.26%)  
7,856/128,172  
-0.101% points  
(-0.287 - +0.084) 
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Table 3: Factors associated with cancer detection rate identified by multilevel logistic regression 550 
models, unadjusted and adjusted for age and previous attendance.  551 
Variable  Unadjusted Model Adjusted model 
 OR (CI) OR (CI) 
FIXED-EFFECTS (measures of association) 
Treatment variable   
Treatment (vs. control) 1.01(0.96-1.06) 1.01(0.97-1.06) 
Background factors   
Age (per year of age)  1.052(1.048-1.055) 
No previous attendance  1.73(1.62-1.86)  
RANDOM-EFFECTS (measures of variation) 
Centre level   
Variance (SE) 0.058(0.012-0.104) 0.038(0.011-0.064) 
   
Intra-centre correlation (%) 1.39 0.96 
MOR 1.26 1.20 
Wald statistics (p-value) 0.014 0.006 
Batch level   
Variance (SE) 0.809(0.754-0.863) 0.595(0.543-0.647) 
   
Intra-batch correlation (%) 20.85 16.13 
MOR 2.35 2.08 
Wald statistics (p-value) <0.001 <0.001 
 
Abbreviations: SE; standard error, CI; confidence interval, MOR; median odds ratio 552 
 553 
 554 
  555 
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Figure Legends 556 
Figure 1: Proposed mechanism of action of changing case order intervention, assuming the 557 
hypothesised vigilance decrement. Each screening represents examining a set of four mammograms, 558 
mediolateral oblique and craniocaudal views of both breasts for one woman. 559 
 560 
 561 
 562 
 563 
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Figure 2: Study flow of trial comparing same vs different order for presenting batches of 564 
mammograms to breast screening readers. 565 
a Each screening included 4 mammograms (mediolateral oblique and craniocaudal views of 566 
both breasts).  567 
bFor each screening there may be multiple reasons why they did not receive the allocated 568 
intervention.  569 
cNational Breast Screening Service (NBSS) records are the electronic health records of 570 
women screened. 571 
  572 
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 574 
 575 
  576 
Analysed 596,642 screenings in 18,779 batches 
(batch size: mean 31.8, median 35, range 1 to 
106) 
Excluded from analysis: 
    Technical Recall (n=6,339 screenings) 
    Subsequent screen of same woman (n=142) 
Lost to follow-up: 
NBSS recordsc not updated (n=172 
screenings) Inconclusive biopsy and did not 
attend any further test (n=115 screenings)  
Recalled for assessment but did not attend 
appointment (n=118 screenings) 
Discontinued intervention (n=0 screenings) 
46 centres participated 
6 declined (4 were not interested, 2 were 
already using the intervention) 
6 did not meet eligibility criteria  
22 were not successfully contacted  
80 Breast Screening Centres in 
England  
Allocated to Intervention Group 18,797 batches 
(n=603,528 screenings, batch size: mean 32.1, 
median 35, range 1 to 107) 

Received allocated intervention (n=523,781) 
Did not receive allocated interventionb but 
included in analysis (n=79,747 screenings): 
Not read in intended order (n=51,599 
screenings) 
Reader trainee (n=26,110 screenings) 
Results entered by administrator not reader 
(n=1 screening) 
Only one reader (n=895 screenings) 
Read using bar code not ordered list 
(n=16,952 screenings) 
No readers (n=1 screening) 
 
Lost to follow-up:  
NBSS recordsc not updated (n=126 
screenings) 
Inconclusive biopsy and did not attend any 
further test (n=118 screenings)  
Recalled for assessment but did not attend 
appointment (n=140 screenings) 
Discontinued intervention (n=0 screenings) 
  
Allocated to Control Group 18,927 batches 
(n=604,105 screenings, batch size: mean 31.9, 
median 35, range 1 to 111). 

Received allocated intervention (n=559,004) 
Did not receive allocated interventionb but 
included in analysis (n= 45,101 screenings): 
Not read in intended order (n=40,528 
screenings) 
Results entered by administrator not reader 
(n=1 screenings) 
Only one reader (n=625 screenings) 
Read using bar code not ordered list 
(n=17,176 screenings) 
No readers (n=0 screenings) 
 
  
Allocation 
Analysed 597,505 screenings in 18,909 batches 
(batch size: mean 31.6, median 34, range 1 to 
110) 
Excluded from analysis: 
    Technical Recall (n=6,087 screenings) 
    Subsequent screen of same woman (n=129) 
  
Analysis 
Enrollment of 
centres 
Follow-Up 
Randomized  
37,724 batches (n=1,207,633 screeningsa batch 
size: mean 32.0, median 35, range 1 to 111)  
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Figure 3 Average patterns of cancer detection rate and recall rate for a single reader over the course 577 
of examining a batch of mammograms.  578 
Each data point represents the mean recall or cancer detection rate over all cases examined by 579 
reader 1 at that position in the batch. 1,173,930 cases are included, examined as reader 1 by 348 580 
readers, median number of screenings per batch position is 21,931 (IQR 10,133 to 28,126). 581 
 582 
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